Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- SWKS +6.7%, (also initiates new $500 mln stock buyback plan), PG +2.9%, ABCB +2.2%, INDB +1.9%, STI +0.9%
Select SWKS peers showing strength:
- QRVO +4.6%, CRUS +3.8%, QCOM +1.1%, TXN +1%
Select oil/gas related names showing strength:
- SHLX +3.4%, SDRL +2.6%, PBR +1.4%, WLL +1.3%, TOT +1.2%, CHK +1.2%, RDS.A +0.5%
Other news:
- BLDP +5.5% ( Protonex received certification from the U.S. Government)
- NGL +4.4% (declares quarterly cash distribution of $0.39/share (fourth and final quarter of the temporary distribution reduction) and provides distribution guidance)
- MRK +3.4% (higher following BMY Opdivo news)
- NVAX +1.5% (announces the initiation of a Phase 2 clinical trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate in older adults)
- SGYP +1.4% (confirms FDA approval for TRULANCE)
Analyst comments:
- EMES +8.3% (upgraded to Buy from Neutral at Goldman)
- CF +5.1% (upgraded to Buy from Underperform at BofA/Merrill)
- NE +5% (upgraded to Neutral from Underperform at BofA/Merrill)